Brigatinib - Alunbrig-@- (Apr 2017)- Anti-cancer

Drug Name:
Brigatinib - Alunbrig-@- (Apr 2017)- Anti-cancer

List Of Brands:

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation

   

Drug Interaction:

DRUG INTERACTIONS
 
 CYP3A Inhibitors: 
 Avoid concomitant use of ALUNBRIG with strong CYP3A inhibitors.
  If concomitant use of a strong CYP3A inhibitor is unavoidable, 
 reduce the dose of ALUNBRIG. 
 
 CYP3A Inducers:
 Avoid concomitant  use of ALUNBRIG with strong CYP3A inducers. 
 
CYP3A Substrates: 
 Hormonal contraceptives may be ineffective due  to decreased exposure.